Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer-Reference-Cited by-同舟云学术

Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer

Published:2017-10-16 Issue:12 Volume:6 Page:2840-2849
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

van der Geest Lydia G. M.¹^ORCID,Haj Mohammad Nadia²,Besselink Marc G. H.³,Lemmens Valery E. P. P.¹⁴,Portielje Johanneke E. A.⁵⁶,van Laarhoven Hanneke W. M.⁷,Wilmink J. Hanneke W.⁷,

Affiliation:

1. Department of Research; Netherlands Comprehensive Cancer Organisation (IKNL); Utrecht The Netherlands

2. Department of Medical Oncology; University Medical Center Utrecht; Utrecht The Netherlands

3. Department of Surgery; Academic Medical Center; Amsterdam The Netherlands

4. Department of Public Health; Erasmus Medical Center; Rotterdam The Netherlands

5. Department of Internal Medicine and Medical Oncology; Haga Hospital; The Hague The Netherlands

6. Foundation of Geriatric Oncology Netherlands (GeriOnNe); Eindhoven The Netherlands

7. Department of Medical Oncology; Academic Medical Center; Amsterdam The Netherlands

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference42 articles.

1. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5;Lepage;Eur. J. Cancer,2015

2. Netherlands Cancer Registry (NCR) http://www.cijfersoverkanker.nl

3. Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands;Bernards;Acta Oncol.,2015

4. Trends in the treatment and outcome of pancreatic cancer in the United States;Baxter;Ann. Surg. Oncol.,2007

5. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008;Worni;Pancreas,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic adenocarcinoma third line systemic treatments: a retrospective cohort study;BMC Cancer;2024-02-26

2. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study;BMC Gastroenterology;2023-08-01

3. Efficacy and Safety of Chemotherapy in Elderly Patients with Unresectable Pancreatic Cancer;Journal of Clinical Medicine;2023-05-08

4. The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients;Journal of Geriatric Oncology;2023-04

5. Chemotherapy effectiveness and age-group analysis of older adult patients with metastatic pancreatic cancer: A Japanese cancer registry cohort study;Journal of Geriatric Oncology;2022-11